Files and links (2)
Published (Version of Record)CC BY V4.0, Open Access
Journal article
Antisense oligonucleotide induction of the hnRNPA1b isoform affects pre-mRNA splicing of SMN2 in SMA type I fibroblasts
International Journal of Molecular Sciences, Vol.23(7), Article 3937
2022
Abstract
Spinal muscular atrophy (SMA) is a severe, debilitating neuromuscular condition characterised by loss of motor neurons and progressive muscle wasting. SMA is caused by a loss of expression of SMN1 that encodes the survival motor neuron (SMN) protein necessary for the survival of motor neurons. Restoration of SMN expression through increased inclusion of SMN2 exon 7 is known to ameliorate symptoms in SMA patients. As a consequence, regulation of pre-mRNA splicing of SMN2 could provide a potential molecular therapy for SMA. In this study, we explored if splice switching antisense oligonucleotides could redirect the splicing repressor hnRNPA1 to the hnRNPA1b isoform and restore SMN expression in fibroblasts from a type I SMA patient. Antisense oligonucleotides (AOs) were designed to promote exon 7b retention in the mature mRNA and induce the hnRNPA1b isoform. RT-PCR and western blot analysis were used to assess and monitor the efficiency of different AO combinations. A combination of AOs targeting multiple silencing motifs in hnRNPA1 pre-mRNA led to robust hnRNPA1b induction, which, in turn, significantly increased expression of full-length SMN (FL-SMN) protein. A combination of PMOs targeting the same motifs also strongly induced hnRNPA1b isoform, but surprisingly SMN2 exon 5 skipping was detected, and the PMO cocktail did not lead to a significant increase in expression of FL-SMN protein. We further performed RNA sequencing to assess the genome-wide effects of hnRNPA1b induction. Some 3244 genes were differentially expressed between the hnRNPA1b-induced and untreated SMA fibroblasts, which are functionally enriched in cell cycle and chromosome segregation processes. RT-PCR analysis demonstrated that expression of the master regulator of these enrichment pathways, MYBL2 and FOXM1B, were reduced in response to PMO treatment. These findings suggested that induction of hnRNPA1b can promote SMN protein expression, but not at sufficient levels to be clinically relevant.
Details
- Title
- Antisense oligonucleotide induction of the hnRNPA1b isoform affects pre-mRNA splicing of SMN2 in SMA type I fibroblasts
- Authors/Creators
- J. Toosaranont (Author/Creator) - Siriraj HospitalS. Ruschadaariyachat (Author/Creator) - Siriraj HospitalW. Mujchariyakul (Author/Creator) - Mahidol UniversityJ.K. Arora (Author/Creator) - Mahidol UniversityV. Charoensawan (Author/Creator) - Mahidol UniversityB. Suktitipat (Author/Creator) - Siriraj HospitalT.N. Palmer (Author/Creator) - Perron Institute for Neurological and Translational ScienceS. Fletcher (Author/Creator) - Murdoch UniversityS.D. Wilton (Author/Creator) - Murdoch UniversityC. Mitrpant (Author/Creator) - Murdoch University
- Publication Details
- International Journal of Molecular Sciences, Vol.23(7), Article 3937
- Publisher
- MDPI
- Identifiers
- 991005544904107891
- Copyright
- © 2022 by the authors
- Murdoch Affiliation
- Centre for Molecular Medicine and Innovative Therapeutics; Health Futures Institute
- Language
- English
- Resource Type
- Journal article
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites
Metrics
10 File views/ downloads
81 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- International collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.255 Musculoskeletal Disorders
- 1.255.2204 Spinal Muscular Atrophy
- Web Of Science research areas
- Biochemistry & Molecular Biology
- Chemistry, Multidisciplinary
- ESI research areas
- Chemistry